Recombinant Gloeobacter violaceus N utilization substance protein B homolog (nusB) refers to a protein whose gene originates from the cyanobacterium Gloeobacter violaceus, produced through recombinant DNA technology. NusB is a protein involved in transcription termination and antitermination, and it interacts with other proteins to regulate gene expression . Gloeobacter violaceus is a species of cyanobacteria known for, among other things, lacking internal membranes .
Due to a lack of direct information on the "Gloeobacter violaceus N utilization substance protein B homolog (nusB)," information on a related protein, Gloeobacter violaceus UPF0060 membrane protein glr4174, and on the nusB protein generally, may provide some insight.
Recombinant Production: The protein is produced using recombinant DNA technology, typically in a host organism like E. coli . This involves cloning the nusB gene from Gloeobacter violaceus into an expression vector and introducing it into the host organism for protein production.
UPF0060 Membrane Protein Glr4174: Gloeobacter violaceus UPF0060 membrane protein glr4174 is a membrane protein that is expressed in E. coli with an N-terminal His tag .
Nitrogen Assimilation: Gloeobacter violaceus uses alanine as a nitrogen source . Computational methods can predict nitrogen assimilation networks in cyanobacteria such as Synechococcus sp. WH 8102, offering insights into how these organisms manage nitrogen utilization .
Protein Interactions: Computational analysis has predicted protein-protein interactions in Synechococcus sp. WH 8102, which may offer insight into the function of the nusB protein .
Drug Discovery: Glycopeptide antibiotics (GPAs) are an important class of drugs effective against multidrug-resistant Gram-positive pathogens . Investigating the natural variety of GPAs from actinobacteria may lead to the discovery of new antibiotics .
Biotechnology: Proteins and enzymes from Gloeobacter violaceus may have applications in biotechnology, such as in the production of novel compounds or biofuels.
Structural Biology: Proteins from Gloeobacter violaceus are used in structural studies to understand protein function.
| Feature | Description |
|---|---|
| Organism of Origin | Gloeobacter violaceus |
| Production Method | Recombinant DNA technology, typically using E. coli as a host organism |
| Function | NusB is involved in transcription termination and antitermination and interacts with other proteins to regulate gene expression. |
| Related protein | Gloeobacter violaceus UPF0060 membrane protein glr4174 |
| Nitrogen source | alanine |
Nitrogen Regulation: Gloeobacter violaceus preferentially uses alanine as a nitrogen source. Growth studies have indicated a preference for alanine as a nitrogen source in cells expressing the G. violaceus transporter .
Antibiotic Production: Nonomuraea coxensis DSM 45129 produces a novel glycopeptide antibiotic (GPA), an A40926 analogue lacking the carboxyl group on the N-acylglucosamine moiety .
Quorum Sensing Inhibition: Some compounds can inhibit violacein production in Chromobacterium violaceum, with potential applications as quorum-sensing inhibitors .
Protein Solubility and Stability: Water solubility and structural stability are key characteristics of proteins, influenced by their primary sequence and 3D conformation .
KEGG: gvi:gll1336
STRING: 251221.gll1336
The nusB gene in Gloeobacter violaceus (strain ATCC 29082/PCC 7421) encodes a protein of 211 amino acids with a molecular mass of approximately 24 kDa . Unlike the nusB gene in some organisms, the G. violaceus nusB gene is localized alone in the genome rather than being clustered with other genes . This contrasts with other cyanobacterial systems like Anabaena opsin, which is clustered together with a 14 kDa transducer gene .
The G. violaceus genome itself is a single circular chromosome of 4,659,019 bp with an average GC content of 62% . The chromosome comprises 4,430 potential protein-encoding genes, including the nusB gene, along with one set of rRNA genes and 45 tRNA genes . This genomic context is important for understanding the evolutionary position and functional role of nusB in this primitive cyanobacterium.
While the specific structure of G. violaceus nusB has not been fully characterized, insights can be drawn from studies on the E. coli homolog. The E. coli NusB protein is a 15.6 kDa monomer as confirmed by analytical ultracentrifugation . Structural studies performed using protein samples labeled with 15N, 13C, and 2H revealed that E. coli NusB has a predominantly alpha-helical structure comprising seven alpha helices .
G. violaceus nusB is larger (24 kDa vs. 15.6 kDa) than its E. coli counterpart , suggesting potential structural differences or additional domains. This size difference may reflect adaptations related to G. violaceus's unique evolutionary position. Based on sequence analysis and homology modeling, researchers can predict that G. violaceus nusB likely maintains the core alpha-helical structure typical of the NusB family while potentially containing unique structural elements that may be related to its function in this primitive cyanobacterium.
Based on established methods for similar proteins, Escherichia coli is the recommended expression system for recombinant G. violaceus nusB. When designing an expression strategy, researchers should consider:
Expression vector selection: Vectors containing T7 or similar strong promoters (like pET series) are typically effective for NusB proteins .
E. coli strain optimization: BL21(DE3) or its derivatives are recommended due to their reduced protease activity and compatibility with T7 expression systems .
Codon optimization: Given the GC-rich genome of G. violaceus (62% GC content) , codon optimization for E. coli expression may improve yields significantly.
Expression conditions: Based on protocols for other recombinant proteins, initial testing should include:
For challenging expressions, consider using specialized E. coli strains like Rosetta (for rare codons) or Arctic Express (for improved folding at lower temperatures).
Statistical experimental design offers advantages over traditional one-variable-at-a-time approaches for optimizing recombinant protein expression. A fractional factorial design can efficiently identify significant variables affecting nusB expression while minimizing the number of experiments .
Key variables to consider in your experimental design include:
| Parameter | Low Level | Center Point | High Level |
|---|---|---|---|
| Temperature | 18°C | 25°C | 30°C |
| IPTG concentration | 0.1 mM | 0.5 mM | 1.0 mM |
| Media composition | Minimal | Semi-rich | Rich |
| Post-induction time | 4h | 8h | 16h |
| Initial cell density | OD₆₀₀ 0.4 | OD₆₀₀ 0.6 | OD₆₀₀ 0.8 |
| pH | 6.5 | 7.0 | 7.5 |
| Aeration rate | Low | Medium | High |
| Inducer type | IPTG | Lactose | Auto-induction |
A 2^8-4 fractional factorial design with center point replicates would require only 24 experimental conditions but provide significant insights into main effects and key interactions . Responses to measure should include:
This multivariate approach allows the estimation of statistically significant variables while considering interactions between them, leading to more robust optimization than traditional methods .
Based on successful purification strategies for E. coli NusB and other similar proteins, a multi-step purification approach is recommended:
Initial capture: Affinity chromatography using a His-tag is recommended for initial capture. The purity achieved at this step is typically 70-80% .
Intermediate purification: Ion-exchange chromatography (preferably anion exchange) helps remove contaminants with different charge properties. This step can increase purity to >90% .
Polishing: Size-exclusion chromatography (gel filtration) serves as an excellent final polishing step, separating any remaining contaminants based on molecular size and achieving >95% purity .
A typical purification table might look like:
| Purification Step | Buffer Composition | Expected Recovery | Purity Achieved |
|---|---|---|---|
| Cell lysis | 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM PMSF | 100% (reference) | <30% |
| IMAC (Ni-NTA) | Binding: Same as lysis buffer Wash: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole Elution: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 250 mM imidazole | 70-80% | 70-80% |
| Anion Exchange | Binding: 20 mM Tris-HCl pH 8.0, 50 mM NaCl Elution: 20 mM Tris-HCl pH 8.0, 50-500 mM NaCl gradient | 60-70% | 85-90% |
| Size Exclusion | 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM DTT | 50-60% | >95% |
For analytical characterization, use SDS-PAGE, Western blotting with anti-His antibodies or custom anti-NusB antibodies (similar to the approach described for Gloeobacter rhodopsin) , and mass spectrometry to confirm protein identity and purity.
To characterize the binding of G. violaceus nusB to its target sequences (particularly the boxA antiterminator sequence), several complementary approaches are recommended:
Electrophoretic Mobility Shift Assay (EMSA):
Generate fluorescently labeled or radioisotope-labeled boxA RNA oligonucleotides
Incubate with increasing concentrations of purified nusB protein
Analyze complex formation by native gel electrophoresis
Determine binding affinity (Kd) through quantification of bound vs. unbound fractions
Surface Plasmon Resonance (SPR):
Immobilize biotinylated boxA RNA on a streptavidin sensor chip
Flow purified nusB protein in increasing concentrations
Measure real-time binding kinetics (kon and koff)
Calculate binding affinity (KD = koff/kon)
Fluorescence Anisotropy:
Label boxA RNA with a fluorescent probe
Measure changes in fluorescence polarization upon nusB binding
Generate binding curves to determine dissociation constants
Filter Binding Assay:
Use radiolabeled RNA and purified protein
Separate bound from unbound RNA using nitrocellulose filters
Quantify bound RNA through scintillation counting
When performing these assays, compare the binding of G. violaceus nusB to both its native boxA sequence and the E. coli equivalent to assess evolutionary conservation or divergence of binding specificity.
To investigate the functional role of G. violaceus nusB in transcription antitermination, researchers should employ both in vitro and in vivo approaches:
Set up a reconstituted transcription system with:
Purified RNA polymerase (either G. violaceus RNA polymerase or E. coli RNA polymerase)
DNA template containing a promoter, the boxA sequence, and a terminator
Purified recombinant G. violaceus nusB protein
Appropriate buffer conditions
Analyze transcription products using gel electrophoresis to determine:
Ratio of terminated vs. readthrough transcripts
Effect of nusB concentration on antitermination efficiency
Requirement for additional factors (e.g., NusA, NusE, NusG)
Construct reporter plasmids with:
G. violaceus rRNA promoter
BoxA sequence from G. violaceus
Intrinsic terminator
Reporter gene (e.g., GFP, luciferase)
Transform into either:
E. coli with its endogenous nusB gene deleted, complemented with G. violaceus nusB
G. violaceus itself, if genetic manipulation systems are available
Measure reporter activity to assess antitermination efficiency under various conditions.
By combining these approaches, researchers can determine whether G. violaceus nusB functions analogously to E. coli nusB or has unique properties reflective of its ancient evolutionary position.
Given that G. violaceus inhabits low-salinity terrestrial habitats such as limestone exposures in Switzerland , it's important to investigate how environmental factors influence nusB function:
Temperature effects:
pH sensitivity:
Test functional activity across pH range 5.0-9.0
Compare with E. coli nusB to identify adaptive differences
Salt concentration effects:
Light-dependent regulation:
Establishing these environmental parameters is critical for optimizing functional assays and understanding the ecological adaptations of G. violaceus nusB.
For comprehensive structural characterization of G. violaceus nusB, multiple complementary spectroscopic approaches should be used:
Based on studies of E. coli NusB , G. violaceus nusB is likely to be predominantly α-helical. CD spectroscopy can rapidly confirm this prediction before proceeding to more resource-intensive techniques like NMR or X-ray crystallography.
Computational approaches provide valuable insights about G. violaceus nusB structure, particularly when experimental structural data is limited:
Homology Modeling:
Use E. coli NusB crystal structure as a template
Apply multiple sequence alignment to identify conserved regions
Generate models using software like MODELLER, SWISS-MODEL, or Rosetta
Evaluate model quality with PROCHECK, VERIFY3D, and QMEAN
Molecular Dynamics Simulations:
Simulate protein behavior in explicit solvent over nanosecond to microsecond timescales
Analyze structural stability, conformational flexibility, and potential binding sites
Investigate the effect of mutations on structure and dynamics
RNA-Protein Docking:
Predict the binding mode of boxA RNA to G. violaceus nusB
Compare with known RNA-protein complexes involving nusB homologs
Identify key residues for experimental validation by mutagenesis
Coevolution Analysis:
Use methods like direct coupling analysis (DCA) to identify co-evolving residues
Infer structural contacts and functional constraints
Guide experimental design for mutagenesis studies
By integrating computational predictions with experimental validation, researchers can develop a comprehensive understanding of G. violaceus nusB structure and function even before high-resolution structures are available.
G. violaceus occupies a unique position as one of the earliest-branching cyanobacteria, lacking thylakoid membranes and exhibiting several primitive features . Studying its nusB protein can provide valuable insights into transcription regulation evolution:
Ancestral Features:
G. violaceus nusB may retain ancestral characteristics that were present in the last common ancestor of cyanobacteria
Comparative analysis with diverse bacterial nusB proteins can identify core conserved features versus lineage-specific adaptations
Regulatory Network Evolution:
Adaptation to Membrane Architecture:
Ribosomal RNA Transcription Regulation:
By combining phylogenetic analysis with functional characterization, researchers can use G. violaceus nusB to reconstruct the ancestral state of transcription antitermination in cyanobacteria and trace its evolutionary trajectory.
A systematic comparison of G. violaceus nusB with homologs from diverse bacteria can reveal functional conservation and specialization:
Functional differences to investigate include:
Binding specificity for boxA sequences (comparing affinity and selectivity)
Interaction partners (NusA, NusE, NusG, RNA polymerase)
Response to environmental signals (temperature, pH, light)
Role in stress responses and adaptation
Understanding these differences can provide insights into how nusB function has been tuned during bacterial evolution to support diverse lifestyles and environmental adaptations.
G. violaceus represents a unique model for studying primitive mechanisms of transcription-translation coupling:
Membrane Localization Studies:
G. violaceus lacks thylakoid membranes, with photosynthesis occurring directly in the cytoplasmic membrane
Investigate potential co-localization of nusB with ribosomes and RNA polymerase at the membrane using fluorescence microscopy or subcellular fractionation
Compare with other cyanobacteria that possess thylakoids to understand evolutionary differences
Coupled in vitro Systems:
Develop a coupled transcription-translation system using G. violaceus components
Compare efficiency with and without nusB to assess its role in coupling
Analyze the effect of energy status (ATP/GTP levels) to investigate links between photosynthesis and gene expression
Interactome Analysis:
Use pull-down assays, crosslinking mass spectrometry, or proximity labeling to identify the complete set of nusB interaction partners
Compare with the interactome of nusB from other bacteria to identify unique features
This research direction could reveal whether the primitive membrane architecture of G. violaceus influences how transcription, translation, and energy metabolism are coordinated at the molecular level.
Given its terrestrial habitat on limestone exposures , G. violaceus likely experiences significant environmental fluctuations. Research into nusB's potential role in stress responses could include:
Transcriptomic Analysis:
Expose G. violaceus to various stresses (desiccation, temperature shifts, light fluctuations)
Use RNA-seq to analyze changes in nusB expression and global transcription patterns
Identify stress-responsive genes potentially regulated through nusB-dependent antitermination
Heterologous Expression in Model Systems:
Express G. violaceus nusB in an E. coli nusB deletion strain
Compare stress survival phenotypes between wild-type E. coli, nusB deletion, and G. violaceus nusB complementation strains
Identify condition-specific functional complementation
Protein-Protein Interaction Changes Under Stress:
Use biochemical or biophysical methods to assess whether stress conditions alter nusB interactions
Investigate potential stress-induced post-translational modifications of nusB
NusB-Dependent Antitermination During Stress:
Design reporter constructs to monitor antitermination efficiency under various stress conditions
Compare with other bacterial systems to identify unique features of the G. violaceus response
These approaches could reveal whether nusB has evolved specialized functions in G. violaceus related to its unique ecological niche and evolutionary position.
If experiencing solubility issues with recombinant G. violaceus nusB, consider these methodological approaches:
Expression Optimization:
Fusion Partners:
Test different solubility-enhancing fusion tags:
Maltose-binding protein (MBP)
NusA tag (ironically, using E. coli NusA as a solubility enhancer)
SUMO tag
Thioredoxin
Buffer Optimization:
Screen various buffer conditions during lysis and purification:
| Component | Concentration Range to Test |
|---|---|
| pH | 6.5-8.5 in 0.5 increments |
| NaCl | 100-500 mM |
| Glycerol | 5-20% |
| Reducing agents | 1-10 mM DTT or 0.5-5 mM TCEP |
| Mild detergents | 0.1% Triton X-100 or 0.05% NP-40 |
| Stabilizing agents | 100-500 mM L-Arginine or 50-200 mM Trehalose |
Co-expression Strategies:
Co-express with chaperones (GroEL/ES, DnaK/J, trigger factor)
Co-express with potential binding partners (if known)
Refolding Protocols:
If inclusion bodies persist, develop a refolding protocol:
Solubilize in 6-8 M urea or 4-6 M guanidine HCl
Remove denaturant by gradual dialysis or rapid dilution
Add oxidized/reduced glutathione pairs to assist disulfide bond formation
Monitor refolding by circular dichroism or fluorescence spectroscopy
These approaches should be tested systematically, potentially using the statistical experimental design mentioned earlier to efficiently identify optimal conditions .
Confirming that purified G. violaceus nusB is properly folded and functional requires multiple complementary approaches:
Biophysical Characterization:
Binding Assays:
Electrophoretic mobility shift assay (EMSA) with boxA RNA
Fluorescence anisotropy or surface plasmon resonance to measure binding kinetics
Compare binding parameters with those of well-characterized nusB proteins
Functional Complementation:
Express G. violaceus nusB in an E. coli ΔnusB strain
Test growth under conditions where nusB function is critical
Assess antitermination efficiency using reporter constructs
Protein-Protein Interaction Tests:
Pull-down assays with potential interaction partners (NusE/S10, RNA polymerase)
Co-immunoprecipitation from cell lysates
Yeast two-hybrid or bacterial two-hybrid systems
A functionally intact G. violaceus nusB should demonstrate:
Stable, well-defined secondary structure
Specific binding to boxA RNA
At least partial complementation of E. coli nusB deficiency
Interaction with conserved partner proteins
By applying these validation approaches, researchers can ensure that their purified protein is suitable for downstream structural and functional studies.